Real-time enrollment status for this neoplasms clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 5:15 AM UTC
| NCT Number | NCT06311578 |
| Recruiting Status | Recruiting |
| Condition | Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 126 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Johnson & Johnson Enterprise Innovation Inc. |
| Last Updated on CT.gov | September 25, 2026 (3 weeks ago) |
As of October 17, 2026: Clinical trial NCT06311578 is currently recruiting participants. This phase1 study for neoplasms is actively seeking new participants at 4 locations across the United States. The study is sponsored by Johnson & Johnson Enterprise Innovation Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06311578 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06311578 was last updated 3 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.